Photo by isaacmsmith from unsplash
Plasmapheresis and hemoperfusion are used against cytokine release syndrome in COVID‐19. This study aims to compare their outcomes, costs, and side‐effects. Click to show full abstract
Plasmapheresis and hemoperfusion are used against cytokine release syndrome in COVID‐19. This study aims to compare their outcomes, costs, and side‐effects.
Keywords:
comparison outcomes;
costs extracorporeal;
purification therapies;
extracorporeal blood;
outcomes costs;
blood purification
Journal Title: Therapeutic Apheresis and Dialysis
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Therapeutic Apheresis and Dialysis
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!